ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Penghong Song
Matched on ORCID iD 0000-0002-5167-1344; OpenAlex author ID A5090404762. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: 1 paper
Papers 2
- Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemotherapy Efficacy against Pancreatic Cancer. Last author DOI 10.1002/advs.202201931↗
- Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer. Last author DOI 10.3892/ijo.2020.5053↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zequn Li · 2 shared papers, 2020–2022 · strength 0.25
- Paper Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemothe… DOI 10.1002/advs.202201931↗
- Paper Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer. DOI 10.3892/ijo.2020.5053↗
- Suchen Bian · 1 shared paper, 2022 · strength 0.14
- Hangxiang Wang · 1 shared paper, 2022 · strength 0.14
- Shusen Zheng · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.